CA Stock MarketDetailed Quotes

AQS Aequus Pharmaceuticals Inc

Watchlist
  • 0.010
  • 0.0000.00%
15min DelayTrading Nov 28 16:00 ET
1.33MMarket Cap-1000P/E (TTM)

Aequus Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
1,010.26%148.32K
64.02%161.41K
-43.03%52.56K
-81.53%254.9K
-86.72%50.88K
-96.16%13.36K
-71.60%98.41K
-69.48%92.25K
-49.17%1.38M
-55.42%383.08K
Operating revenue
1,010.26%148.32K
64.02%161.41K
-43.03%52.56K
-81.53%254.9K
-86.72%50.88K
-96.16%13.36K
-71.60%98.41K
-69.48%92.25K
-49.17%1.38M
-55.42%383.08K
Cost of revenue
596.87%72.88K
86.23%86.56K
-54.88%17.59K
7.41%111.23K
-72.91%15.3K
-57.52%10.46K
267.16%46.48K
298.64%38.99K
142.08%103.56K
129.04%56.5K
Gross profit
2,500.52%75.44K
44.15%74.85K
-34.35%34.96K
-88.74%143.66K
-89.11%35.57K
-99.10%2.9K
-84.45%51.93K
-81.79%53.26K
-52.24%1.28M
-60.87%326.58K
Operating expense
-19.55%623.39K
2.30%736.56K
-15.97%645.5K
-21.47%2.96M
-6.72%700.97K
-8.70%774.83K
-33.03%719.98K
-30.10%768.16K
-6.56%3.77M
-28.56%751.51K
Selling and administrative expenses
-11.36%590.3K
6.68%703.48K
15.11%612.42K
-27.37%2.52M
-17.45%667.05K
-17.88%665.98K
-36.31%659.41K
-35.21%532.06K
-3.84%3.48M
-17.39%808.07K
-Selling and marketing expense
407.61%446.58K
54.71%145.9K
59.40%94.58K
-32.47%385.94K
16.29%144.32K
-38.81%87.98K
-56.24%94.31K
-87.36%59.34K
37.96%571.53K
-25.03%124.1K
-General and administrative expense
-75.14%143.72K
-1.33%557.58K
9.54%517.84K
-26.36%2.14M
-23.57%522.73K
-13.37%578.01K
-31.08%565.11K
34.44%472.72K
-9.25%2.9M
-15.83%683.97K
Research and development costs
--0
--0
--0
78.57%301.28K
--0
1,126.54%74.1K
225.03%25.82K
-18.18%201.36K
-43.16%168.71K
-271.02%-91.38K
Depreciation amortization depletion
-4.79%33.08K
-4.79%33.08K
-4.79%33.08K
6.42%138.16K
-2.57%33.92K
9.71%34.75K
9.71%34.75K
9.71%34.75K
1.34%129.83K
70.65%34.81K
-Depreciation and amortization
-4.79%33.08K
-4.79%33.08K
-4.79%33.08K
6.42%138.16K
-2.57%33.92K
9.71%34.75K
9.71%34.75K
9.71%34.75K
1.34%129.83K
70.65%34.81K
Operating profit
29.02%-547.94K
0.95%-661.71K
14.60%-610.54K
-12.90%-2.82M
-56.59%-665.4K
-46.93%-771.93K
9.87%-668.06K
11.36%-714.9K
-82.68%-2.5M
-95.53%-424.93K
Net non-operating interest income (expenses)
-93.32%-67.74K
-86.99%-60.31K
-77.48%-51.65K
25.49%-141.05K
-54.91%-44.66K
-375.49%-35.04K
30.23%-32.25K
72.77%-29.1K
57.14%-189.3K
73.10%-28.83K
Non-operating interest income
-63.12%274
4,135.29%720
77.06%687
-83.26%4.14K
6.26%2.99K
-92.41%743
-99.75%17
-92.51%388
87.41%24.71K
-47.76%2.81K
Non-operating interest expense
90.07%68.01K
89.12%61.03K
77.47%52.34K
-32.16%145.18K
50.59%47.64K
108.58%35.78K
-39.30%32.27K
-73.68%29.49K
-52.95%214.01K
-71.89%31.64K
Other net income (expenses)
-71.28%951
6,975.31%38.98K
132.18%102
99.35%-3.39K
98.97%-5.82K
-89.74%3.31K
-103.70%-567
90.93%-317
-108,345.64%-522.71K
-19,649.86%-566.82K
Gain on sale of security
-71.28%951
-619.22%-4.08K
132.18%102
-107.69%-3.39K
-8,847.69%-5.82K
-89.74%3.31K
-103.70%-567
90.93%-317
9,238.59%44.05K
97.74%-65
Special income (charges)
----
----
----
--0
----
----
----
----
---566.76K
----
-Less:Write off
----
----
----
--0
----
----
----
----
--566.76K
----
Other non-operating income (expenses)
----
--43.06K
----
----
----
----
----
----
----
----
Income before tax
23.51%-614.73K
2.55%-683.03K
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
9.23%-700.88K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
Income tax
Earnings from equity interest net of tax
Net income
23.51%-614.73K
2.55%-683.03K
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
9.23%-700.88K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
Net income continuous operations
23.51%-614.73K
2.55%-683.03K
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
9.23%-700.88K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
Noncontrolling interests
Net income attributable to the company
23.51%-614.73K
2.55%-683.03K
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
9.23%-700.88K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
23.51%-614.73K
2.55%-683.03K
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
9.23%-700.88K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
Diluted earnings per share
0.00%-0.01
0.00%-0.01
50.08%-0.005
0.00%-0.02
0
-165.04%-0.01
0.00%-0.01
0.00%-0.01
-100.00%-0.02
0
Basic earnings per share
0.00%-0.01
0.00%-0.01
50.08%-0.005
0.00%-0.02
0
-165.04%-0.01
0.00%-0.01
0.00%-0.01
-100.00%-0.02
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 1,010.26%148.32K64.02%161.41K-43.03%52.56K-81.53%254.9K-86.72%50.88K-96.16%13.36K-71.60%98.41K-69.48%92.25K-49.17%1.38M-55.42%383.08K
Operating revenue 1,010.26%148.32K64.02%161.41K-43.03%52.56K-81.53%254.9K-86.72%50.88K-96.16%13.36K-71.60%98.41K-69.48%92.25K-49.17%1.38M-55.42%383.08K
Cost of revenue 596.87%72.88K86.23%86.56K-54.88%17.59K7.41%111.23K-72.91%15.3K-57.52%10.46K267.16%46.48K298.64%38.99K142.08%103.56K129.04%56.5K
Gross profit 2,500.52%75.44K44.15%74.85K-34.35%34.96K-88.74%143.66K-89.11%35.57K-99.10%2.9K-84.45%51.93K-81.79%53.26K-52.24%1.28M-60.87%326.58K
Operating expense -19.55%623.39K2.30%736.56K-15.97%645.5K-21.47%2.96M-6.72%700.97K-8.70%774.83K-33.03%719.98K-30.10%768.16K-6.56%3.77M-28.56%751.51K
Selling and administrative expenses -11.36%590.3K6.68%703.48K15.11%612.42K-27.37%2.52M-17.45%667.05K-17.88%665.98K-36.31%659.41K-35.21%532.06K-3.84%3.48M-17.39%808.07K
-Selling and marketing expense 407.61%446.58K54.71%145.9K59.40%94.58K-32.47%385.94K16.29%144.32K-38.81%87.98K-56.24%94.31K-87.36%59.34K37.96%571.53K-25.03%124.1K
-General and administrative expense -75.14%143.72K-1.33%557.58K9.54%517.84K-26.36%2.14M-23.57%522.73K-13.37%578.01K-31.08%565.11K34.44%472.72K-9.25%2.9M-15.83%683.97K
Research and development costs --0--0--078.57%301.28K--01,126.54%74.1K225.03%25.82K-18.18%201.36K-43.16%168.71K-271.02%-91.38K
Depreciation amortization depletion -4.79%33.08K-4.79%33.08K-4.79%33.08K6.42%138.16K-2.57%33.92K9.71%34.75K9.71%34.75K9.71%34.75K1.34%129.83K70.65%34.81K
-Depreciation and amortization -4.79%33.08K-4.79%33.08K-4.79%33.08K6.42%138.16K-2.57%33.92K9.71%34.75K9.71%34.75K9.71%34.75K1.34%129.83K70.65%34.81K
Operating profit 29.02%-547.94K0.95%-661.71K14.60%-610.54K-12.90%-2.82M-56.59%-665.4K-46.93%-771.93K9.87%-668.06K11.36%-714.9K-82.68%-2.5M-95.53%-424.93K
Net non-operating interest income (expenses) -93.32%-67.74K-86.99%-60.31K-77.48%-51.65K25.49%-141.05K-54.91%-44.66K-375.49%-35.04K30.23%-32.25K72.77%-29.1K57.14%-189.3K73.10%-28.83K
Non-operating interest income -63.12%2744,135.29%72077.06%687-83.26%4.14K6.26%2.99K-92.41%743-99.75%17-92.51%38887.41%24.71K-47.76%2.81K
Non-operating interest expense 90.07%68.01K89.12%61.03K77.47%52.34K-32.16%145.18K50.59%47.64K108.58%35.78K-39.30%32.27K-73.68%29.49K-52.95%214.01K-71.89%31.64K
Other net income (expenses) -71.28%9516,975.31%38.98K132.18%10299.35%-3.39K98.97%-5.82K-89.74%3.31K-103.70%-56790.93%-317-108,345.64%-522.71K-19,649.86%-566.82K
Gain on sale of security -71.28%951-619.22%-4.08K132.18%102-107.69%-3.39K-8,847.69%-5.82K-89.74%3.31K-103.70%-56790.93%-3179,238.59%44.05K97.74%-65
Special income (charges) --------------0-------------------566.76K----
-Less:Write off --------------0------------------566.76K----
Other non-operating income (expenses) ------43.06K--------------------------------
Income before tax 23.51%-614.73K2.55%-683.03K11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K9.23%-700.88K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M
Income tax
Earnings from equity interest net of tax
Net income 23.51%-614.73K2.55%-683.03K11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K9.23%-700.88K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M
Net income continuous operations 23.51%-614.73K2.55%-683.03K11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K9.23%-700.88K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M
Noncontrolling interests
Net income attributable to the company 23.51%-614.73K2.55%-683.03K11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K9.23%-700.88K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 23.51%-614.73K2.55%-683.03K11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K9.23%-700.88K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M
Diluted earnings per share 0.00%-0.010.00%-0.0150.08%-0.0050.00%-0.020-165.04%-0.010.00%-0.010.00%-0.01-100.00%-0.020
Basic earnings per share 0.00%-0.010.00%-0.0150.08%-0.0050.00%-0.020-165.04%-0.010.00%-0.010.00%-0.01-100.00%-0.020
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data